237 related articles for article (PubMed ID: 21996089)
1. SUVmax during 18FDG-PET scanning in small cell lung cancer: similar information as in non-small cell lung cancer?
van der Leest C; Smit EF; Baas J; Versteijlen RJ; van Walree N; Hoogsteden HC; Aerts JG
Lung Cancer; 2012 Apr; 76(1):67-71. PubMed ID: 21996089
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of FDG uptake in early stage non-small cell lung cancer.
Hanin FX; Lonneux M; Cornet J; Noirhomme P; Coulon C; Distexhe J; Poncelet AJ
Eur J Cardiothorac Surg; 2008 May; 33(5):819-23. PubMed ID: 18374589
[TBL] [Abstract][Full Text] [Related]
3. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced non-small cell lung cancer treated by non-surgical therapy.
Yan H; Wang R; Zhao F; Zhu K; Jiang S; Zhao W; Feng R
Acta Radiol; 2011 Jul; 52(6):646-50. PubMed ID: 21508201
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of pre-treatment
Aktan M; Koc M; Kanyilmaz G; Yavuz BB
Ann Nucl Med; 2017 Jul; 31(6):462-468. PubMed ID: 28516335
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of different metabolic measurements with fluorine-18 fluorodeoxyglucose positron emission tomography in resectable non-small cell lung cancer: a two-center study.
de Jong WK; van der Heijden HF; Pruim J; Dalesio O; Oyen WJ; Groen HJ
J Thorac Oncol; 2007 Nov; 2(11):1007-12. PubMed ID: 17975491
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
Li X; Zhang H; Xing L; Xu X; Xie P; Ma H; Zhang L; Chen M; Sun X; Xu W; Chen L; Yu J
Clin Lung Cancer; 2013 Sep; 14(5):568-73. PubMed ID: 23835164
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment [18F]-fluoro-2-deoxy-glucose positron emission tomography maximum standardized uptake value as predictor of distant metastasis in early-stage non-small cell lung cancer treated with definitive radiation therapy: rethinking the role of positron emission tomography in personalizing treatment based on risk status.
Nair VJ; MacRae R; Sirisegaram A; Pantarotto JR
Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):312-8. PubMed ID: 24411602
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of Standardized Uptake Value of Lymph Nodes on Survival for Stage III Non-small Cell Lung Cancer Treated With Definitive Concurrent Chemoradiotherapy.
Lee VH; Chan WW; Lee EY; Choy TS; Ho PP; Leung DK; Lam KO; Kwong DL; Leung TW; Khong PL
Am J Clin Oncol; 2016 Aug; 39(4):355-62. PubMed ID: 24710123
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
Chen HH; Chiu NT; Su WC; Guo HR; Lee BF
Radiology; 2012 Aug; 264(2):559-66. PubMed ID: 22692034
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of maximum standardized uptake value of primary tumor in surgically treated non-small-cell lung cancer patients: analysis of 413 cases.
Billè A; Okiror L; Skanjeti A; Errico L; Arena V; Penna D; Ardissone F; Pelosi E
Clin Lung Cancer; 2013 Mar; 14(2):149-56. PubMed ID: 22682667
[TBL] [Abstract][Full Text] [Related]
12. Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.
Hyun SH; Choi JY; Kim K; Kim J; Shim YM; Um SW; Kim H; Lee KH; Kim BT
Ann Surg; 2013 Feb; 257(2):364-70. PubMed ID: 22968069
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of metabolic parameters measured by (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with small cell lung cancer.
Zhu D; Ma T; Niu Z; Zheng J; Han A; Zhao S; Yu J
Lung Cancer; 2011 Sep; 73(3):332-7. PubMed ID: 21292341
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of 18F-FDG uptake on positron emission tomography in patients with pathologic stage I non-small cell lung cancer.
Um SW; Kim H; Koh WJ; Suh GY; Chung MP; Kwon OJ; Choi JY; Han J; Lee KS; Kim J
J Thorac Oncol; 2009 Nov; 4(11):1331-6. PubMed ID: 19701106
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of FDG uptake in primary inoperable non-small cell lung cancer.
Tong AN; Han SR; Yan P; Gong H; Zhao H; Yao H; Wang YM
Med Oncol; 2014 Jan; 31(1):780. PubMed ID: 24326983
[TBL] [Abstract][Full Text] [Related]
16. Clinical Significance of Positron Emission Tomography in Subcentimeter Non-Small Cell Lung Cancer.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
Ann Thorac Surg; 2017 May; 103(5):1614-1620. PubMed ID: 27964917
[TBL] [Abstract][Full Text] [Related]
17. Effect of PET/CT standardized uptake values on complete response to treatment before definitive chemoradiotherapy in stage III non-small cell lung cancer.
Ercelep O; Alan O; Sahin D; Telli TA; Salva H; Tuylu TB; Babacan NA; Kaya S; Dane F; Ones T; Alkis H; Adli M; Yumuk F
Clin Transl Oncol; 2019 Apr; 21(4):499-504. PubMed ID: 30229391
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of 18-FDG uptake in early stage NSCLC.
Chen JC; Huang TW; Cheng YL; Chang H; Tzao C; Huang WS; Lee SC
Thorac Cardiovasc Surg; 2009 Oct; 57(7):413-6. PubMed ID: 19795329
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of SUVmax measurements obtained by FDG-PET in patients with non-small cell lung cancer receiving chemotherapy.
Imamura Y; Azuma K; Kurata S; Hattori S; Sasada T; Kinoshita T; Okamoto M; Kawayama T; Kaida H; Ishibashi M; Aizawa H
Lung Cancer; 2011 Jan; 71(1):49-54. PubMed ID: 20430470
[TBL] [Abstract][Full Text] [Related]
20. The Highest Metabolic Activity on FDG PET Is Associated With Overall Survival in Limited-Stage Small-Cell Lung Cancer.
Kwon SH; Hyun SH; Yoon JK; An YS; Oh YT; Choi JH; Park KJ; Lee SJ
Medicine (Baltimore); 2016 Feb; 95(5):e2772. PubMed ID: 26844524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
